Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 5 results out of 5

Company Profiles

Access comprehensive reports covering all the major players in the pharmaceutical industry

Buy Now

Data Insights

QTX-3034 is under clinical development by Quanta Therapeutics and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...

Data Insights

QTX-3034 is under clinical development by Quanta Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...

Data Insights

QTX-3034 is under clinical development by Quanta Therapeutics and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...

Data Insights

QTX-3034 is under clinical development by Quanta Therapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...

Data Insights

QTX-3034 is under clinical development by Quanta Therapeutics and currently in Phase I for Lung Cancer. According to GlobalData, Phase...